Compare studies and check their requirements with the research team.
This study is looking at a support or therapy approach for people with First or early psychosis, Mental and Behavioural Disorders, or Psychosis. Participants take part in the program or support approach and complete follow-up assessments.
In United KingdomThis study is directly about Schizophrenia.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Czech RepublicThis study is directly about Schizophrenia.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Czech RepublicThis study is directly about Schizophrenia.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In FranceThis study is directly about Schizophrenia.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In NetherlandsThis study is directly about Schizophrenia.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In ItalyThis study is directly about Schizophrenia.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Czech RepublicThis study is directly about Schizophrenia.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In United KingdomThis study is directly about Schizophrenia.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In AustriaThis study is directly about Schizophrenia.
This study is looking at care and outcomes for people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Taking part may give some people access to 1, but direct benefit is not guaranteed.
In United KingdomThis study is directly about Schizophrenia.
This study is testing a medication approach for people with Schizophrenia, schizotypal and delusional disorders or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
In United KingdomThis study is directly about Schizophrenia.
This study is looking at whether This is a randomised, double-blind, 40 IU intranasal oxytocin versus placebo single-dose challenge with a crossover design (1-week washout) can help people with Schizophrenia, schizotypal and delusional disorders or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
In United KingdomThis study is directly about Schizophrenia.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.